These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37778994)

  • 41. Water Extract of
    Jeong Y; Lee SH; Lee J; Kim MS; Lee YG; Hwang JT; Choi SY; Yoon HG; Lim TG; Lee SH; Choi HK
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958893
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy.
    Pandey S; Kuo WW; Shen CY; Yeh YL; Ho TJ; Chen RJ; Chang RL; Pai PY; Viswanadha VP; Huang CY; Huang CY
    Am J Physiol Cell Physiol; 2019 Aug; 317(2):C235-C243. PubMed ID: 31116582
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective effect of Di'ao Xinxuekang capsule against doxorubicin-induced chronic cardiotoxicity.
    Li X; Liang J; Qin A; Wang T; Liu S; Li W; Yuan C; Qu L; Zou W
    J Ethnopharmacol; 2022 Apr; 287():114943. PubMed ID: 34954266
    [TBL] [Abstract][Full Text] [Related]  

  • 44. p38δ genetic ablation protects female mice from anthracycline cardiotoxicity.
    George SA; Kiss A; Obaid SN; Venegas A; Talapatra T; Wei C; Efimova T; Efimov IR
    Am J Physiol Heart Circ Physiol; 2020 Oct; 319(4):H775-H786. PubMed ID: 32822209
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardioprotective effect of allyl isothiocyanate in a rat model of doxorubicin acute toxicity.
    Waz S; Matouk AI
    Toxicol Mech Methods; 2022 Mar; 32(3):194-203. PubMed ID: 34635025
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Liraglutide ameliorates cardiotoxicity induced by doxorubicin in rats through the Akt/GSK-3β signaling pathway.
    Abbas NAT; Kabil SL
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Nov; 390(11):1145-1153. PubMed ID: 28780599
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mulberrin Confers Protection against Doxorubicin-Induced Cardiotoxicity via Regulating AKT Signaling Pathways in Mice.
    Ye P; Li WL; Bao LT; Ke W
    Oxid Med Cell Longev; 2022; 2022():2967142. PubMed ID: 35847586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardioprotective effects of minocycline against doxorubicin-induced cardiotoxicity.
    Naderi Y; Khosraviani S; Nasiri S; Hajiaghaei F; Aali E; Jamialahmadi T; Banach M; Sahebkar A
    Biomed Pharmacother; 2023 Feb; 158():114055. PubMed ID: 36495663
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Role of mTOR in Doxorubicin-Altered Cardiac Metabolism: A Promising Therapeutic Target of Natural Compounds.
    Yarmohammadi F; Hesari M; Shackebaei D
    Cardiovasc Toxicol; 2024 Feb; 24(2):146-157. PubMed ID: 38108960
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tirzepatide protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress and inflammation via PI3K/Akt signaling.
    Chen L; Chen X; Ruan B; Yang H; Yu Y
    Peptides; 2024 Aug; 178():171245. PubMed ID: 38801993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Crude terpene glycoside component from Radix paeoniae rubra protects against isoproterenol-induced myocardial ischemic injury via activation of the PI3K/AKT/mTOR signaling pathway.
    Ke Z; Wang G; Yang L; Qiu H; Wu H; Du M; Chen J; Song J; Jia X; Feng L
    J Ethnopharmacol; 2017 Jul; 206():160-169. PubMed ID: 28549860
    [TBL] [Abstract][Full Text] [Related]  

  • 52. α-Linolenic acid attenuates doxorubicin-induced cardiotoxicity in rats through suppression of oxidative stress and apoptosis.
    Yu X; Cui L; Zhang Z; Zhao Q; Li S
    Acta Biochim Biophys Sin (Shanghai); 2013 Oct; 45(10):817-26. PubMed ID: 23896563
    [TBL] [Abstract][Full Text] [Related]  

  • 53. C1qTNF-related protein-6 protects against doxorubicin-induced cardiac injury.
    Zheng WF; Zhang SY; Ma HF; Chang XW; Wang H
    J Cell Biochem; 2019 Jun; 120(6):10748-10755. PubMed ID: 30719766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Choline Inhibits Ischemia-Reperfusion-Induced Cardiomyocyte Autophagy in Rat Myocardium by Activating Akt/mTOR Signaling.
    Hang P; Zhao J; Su Z; Sun H; Chen T; Zhao L; Du Z
    Cell Physiol Biochem; 2018; 45(5):2136-2144. PubMed ID: 29533930
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Androgen receptor counteracts Doxorubicin-induced cardiotoxicity in male mice.
    Ikeda Y; Aihara K; Akaike M; Sato T; Ishikawa K; Ise T; Yagi S; Iwase T; Ueda Y; Yoshida S; Azuma H; Walsh K; Tamaki T; Kato S; Matsumoto T
    Mol Endocrinol; 2010 Jul; 24(7):1338-48. PubMed ID: 20501642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Allicin ameliorates doxorubicin-induced cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis.
    Abdel-Daim MM; Kilany OE; Khalifa HA; Ahmed AAM
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):745-753. PubMed ID: 28785995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spinacetin alleviates doxorubicin-induced cardiotoxicity by initiating protective autophagy through SIRT3/AMPK/mTOR pathways.
    Liu D; Zhao L
    Phytomedicine; 2022 Jul; 101():154098. PubMed ID: 35430482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protective effects of olmesartan and l-carnitine on doxorubicin-induced cardiotoxicity in rats.
    Aziz MM; Abd El Fattah MA; Ahmed KA; Sayed HM
    Can J Physiol Pharmacol; 2020 Apr; 98(4):183-193. PubMed ID: 31665614
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways.
    Wei T; Xiaojun X; Peilong C
    Biomed Pharmacother; 2020 Jan; 121():109139. PubMed ID: 31707337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hydrogen inhalation enhances autophagy via the AMPK/mTOR pathway, thereby attenuating doxorubicin-induced cardiac injury.
    Ma T; Yang L; Zhang B; Lv X; Gong F; Yang W
    Int Immunopharmacol; 2023 Jun; 119():110071. PubMed ID: 37080067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.